Carolyn Dresler, MD, MPA, and Chris Bostic, JD, say plans to reduce the prevalence and impact of lung cancer must address smoking if they are to succeed. Read more
Prof. Denis Horgan, executive director for the European Alliance for Personalised Medicine, writes that while the intentions behind the EU’s new cancer screening recommendations are laudable, they lack a roadmap for turning ideas into reality. Read more
Analysis of worldwide epidemiologic patterns may help governments and medical institutions formulate targeted strategies for addressing mesothelioma. Read more
The International Association for the Study of Lung Cancer (IASLC)—as an international organization of lung cancer experts who serves patients in both developed and developing countries, as well as vulnerable […] Read more
Many of Europe’s achievements and commitments have been exemplary in the development of health-related science, technology, and regulation, and the European Union (EU) is on the brink of providing further […] Read more
By Abdul Rahman Jazieh, MD, MPH Posted: August 21, 2020 Countries in the Middle East and North Africa region have significant variation in their socioeconomic status, healthcare resources, infrastructure, and […] Read more
By Ricardo Sales dos Santos, MD, PhD, and Juliana Franceschini, PhD Posted: June 24, 2020 Dr. Juliana Franceschini Dr. Ricardo Sales dos Santos […] Read more
By Linda Coate, MD, FRCPI, and Hazel O’Sullivan, MB, Bch, BAO, MRCPI Posted: August 14, 2019 Dr. Linda Coate Dr. Hazel O’Sullivan […] Read more
By Yeol Kim, MD, MPH, PhD, and Choon-Taek Lee, MD, PhD Posted: August 14, 2019 Lung cancer is the leading cause of cancer death worldwide and also in South Korea. Besides […] Read more
By Joy Curzio Posted: April 1, 2019 Lung cancer is the leading cause of cancer death among women, with the 5-year survival rate at just 21%.1 An estimated 70,500 women in […] Read more